Genomic Cancer Panel And Profiling Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the genomic cancer panel and profiling market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Genomic Cancer Panel And Profiling Market Be Worth By 2029, And What CAGR Will It Achieve?

The genomic cancer panel and profiling market has experienced substantial growth in recent years. This market is anticipated to expand from $9.47 billion in 2024 to $10.28 billion in 2025, maintaining an 8.6% compound annual growth rate (CAGR). Factors contributing to its historical growth include an escalating global cancer burden, increased application in clinical trials, the expansion of diagnostic infrastructure, growing awareness surrounding genetic testing, and a rise in government and research funding.

The genomic cancer panel and profiling market size is anticipated to experience substantial growth in the coming years, with projections indicating it will reach $14.27 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.5%. This expansion during the forecast period is primarily driven by the increasing application of liquid biopsy, its rising utilization in early detection, advancements in tailored therapies, and a growing number of companion diagnostics approvals. Key trends expected in this period include the integration of artificial intelligence and machine learning in genomic data interpretation, the development of multi-omics approaches, the adoption of cloud-based genomic data storage and analysis, integration with electronic health records, and the broader implementation of next-generation sequencing (NGS) platforms.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp

Which Factors Are Driving The Genomic Cancer Panel And Profiling Market Forward?

The increasing occurrence of cancer is anticipated to fuel the expansion of the genomic cancer panel and profiling market in the future. Cancer is a condition marked by the unchecked growth and spread of abnormal cells within the body. The rise in cancer incidence can be linked to elements like an aging population, as longer lifespans contribute to a greater risk of developing the disease. Genomic cancer panels and profiling are utilized in cancer treatment to identify genetic mutations and biomarkers, thereby enabling personalized treatment plans and improving early detection and monitoring of the illness. For instance, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2022, roughly 20 million new cancer cases were recorded globally, resulting in 9.7 million deaths; primarily driven by population growth, the global cancer burden is projected to increase to 35 million cases by 2050. Therefore, the growing incidence of cancer is set to propel the genomic cancer panel and profiling market forward.

Which Segments Form The Key Structure Of The Genomic Cancer Panel And Profiling Market?

The genomic cancer panel and profiling market covered in this report is segmented –

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies

3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel

4) By Application: Clinical, Research

5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues

2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

What Strategic Shifts And Innovations Are Influencing The Genomic Cancer Panel And Profiling Market?

Leading firms within the genomic cancer panel and profiling market are concentrating on innovations like next-generation sequencers to elevate the precision, pace, and thoroughness of cancer diagnostics, thereby facilitating more tailored treatment choices. These sequencers represent sophisticated DNA sequencing techniques that allow for quick, large-scale examination of genetic material to pinpoint mutations, variations, and various genomic characteristics. As an illustration, in April 2025, the Netherlands-based biotechnology company QIAGEN N.V. introduced QIAseq panels, specifically developed for next-generation sequencers, which permit extensive genomic profiling through the analysis of over 700 genes. The purpose of these panels extends to both investigative studies and clinical uses, with the goal of enhancing cancer diagnostic methods and therapeutic approaches.

Which Firms Are Making The Biggest Impact In The Genomic Cancer Panel And Profiling Market?

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/genomic-cancer-panel-and-profiling-global-market-report

Which Region Is Expected To Lead The Genomic Cancer Panel And Profiling Market In The Next Few Years?

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp

Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2025, By The Business Research Company

Genomics In Cancer Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Urothelial Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urothelial-cancer-drugs-global-market-report

Ovarian Cancer Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795